Evidence map›Paper›PMID 24807418›Full record

ArticleNature communications2014

A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation.

Michael L van de Weijer, Michael C Bassik, Rutger D Luteijn, Cornelia M Voorburg, Mirjam A M Lohuis, Elisabeth Kremmer, Rob C Hoeben, Emily M LeProust, Siyuan Chen, Hanneke Hoelen and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Turnover of EDEM1, an ERAD-enhancing factor, is mediated by multiple degradation routes.Genes to cells : devoted to molecular & cellular mechanisms · 2024
    Article
  10. Article
  11. Article
  12. Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Endoplasmic Reticulum-Associated Protein Degradation.Cold Spring Harbor perspectives in biology · 2022
    Review
  20. Viruses Hijack ERAD to Regulate Their Replication and Propagation.International journal of molecular sciences · 2022
    Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Michael L van de WeijerMedical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Michael C Bassik1] Department of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research, Howard Hughes Medical Institute, University of California, San Francisco, California 94158, USA [2].
Rutger D LuteijnMedical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Cornelia M VoorburgMedical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Mirjam A M LohuisMedical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Elisabeth KremmerHelmholtz Zentrum München, German Research Center for Environmental Health, Institute of Molecular Immunology, 81377 Munich, Germany.
Rob C HoebenDepartment of Molecular Cell Biology, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
Emily M LeProust1] Genomics Solution Unit, Agilent Technologies Inc., Santa Clara, California 95051, USA [2].
Siyuan Chen1] Genomics Solution Unit, Agilent Technologies Inc., Santa Clara, California 95051, USA [2].
Hanneke HoelenMedical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Maaike E Ressing1] Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands [2] Department of Molecular Cell Biology, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
Weronika Patena1] Department of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research, Howard Hughes Medical Institute, University of California, San Francisco, California 94158, USA [2] Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA [3].
Jonathan S WeissmanDepartment of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research, Howard Hughes Medical Institute, University of California, San Francisco, California 94158, USA.
Michael T McManusDepartment of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.
Emmanuel J H J Wiertz1] Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands [2].
Robert Jan Lebbink1] Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands [2].
University Medical Center Utrecht · NLHoward Hughes Medical Institute · USAgilent Technologies (United States) · USLeiden University Medical Center · NLHelmholtz Zentrum München · DEUniversity of California, San Francisco · US

Funding

Bay Area Cancer Target Discovery and Development NetworkU01CA168370 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCORMICK, FRANK PATRICK, MCMANUS, MICHAEL T · 2012 to 2016
$3.9M
New Frontiers for Small RNA TherapiesR01GM080783 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCMANUS, MICHAEL T · 2007 to 2011
$1.5M
NCI NIH HHS 1U01CA168370-01NCI NIH HHS U01 CA168370NIGMS NIH HHS R01 GM080783NIGMS NIH HHS R01 GM80783
6 · The paper itself

Abstract

Misfolded ER proteins are retrotranslocated into the cytosol for degradation via the ubiquitin-proteasome system. The human cytomegalovirus protein US11 exploits this ER-associated protein degradation (ERAD) pathway to downregulate HLA class I molecules in virus-infected cells, thereby evading elimination by cytotoxic T-lymphocytes. US11-mediated degradation of HLA class I has been instrumental in the identification of key components of mammalian ERAD, including Derlin-1, p97, VIMP and SEL1L. Despite this, the process governing retrotranslocation of the substrate is still poorly understood. Here using a high-coverage genome-wide shRNA library, we identify the uncharacterized protein TMEM129 and the ubiquitin-conjugating E2 enzyme UBE2J2 to be essential for US11-mediated HLA class I downregulation. TMEM129 is an unconventional C4C4-type RING finger E3 ubiquitin ligase that resides within a complex containing various other ERAD components, including Derlin-1, Derlin-2, VIMP and p97, indicating that TMEM129 is an integral part of the ER-resident dislocation complex mediating US11-induced HLA class I degradation.

Indexed as

RNA InterferenceAdenosine TriphosphatasesCell Line, TumorClustered Regularly Interspaced Short Palindromic RepeatsCytomegalovirusCytomegalovirus InfectionsDown-RegulationEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationHEK293 CellsHistocompatibility Antigens Class IHumansMembrane ProteinsNuclear ProteinsProtein FoldingProteinsAdenosine TriphosphatasesDERL1 protein, humanHistocompatibility Antigens Class IMembrane ProteinsNuclear Proteinsp97 ATPaseProteinsRNA-Binding ProteinsRNA, Small InterferingSEL1L protein, humanSelenoproteinsSELENOS protein, humanTMEM129 protein, humanUBE2J2 protein, humanUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesUS11 protein, herpesvirusViral Proteins

Identifiers

PMID24807418
PMCPMC4024746
OpenAlexW1989422196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.